2004 Press Releases

12.15.04
IGI Inc. and UCT Sign Marketing Joint Venture

11.18.04
IGI Inc. Signs New Three Year License Agreement with a Major Customer

11.12.04
IGI Inc. Files SEC form 10-Q, Quarterly Report

11.8.04
IGI to Report 3rd Quarter 2004 Financial Results on Friday November 12, 2004

11.8.04
nanotechnology Products have impact

11.2.04
New Wrinkle to Research

10.18.04
IGI signs a product development and manufacturing agreement with Universe Cosmetics, Inc.

10.15.04
Relieva with Psorberine - Mahonia aquifolium 10%, a homeopathic product is using IGI's Novasome Transdermal delivery system

8.2.04
IGI Inc. Signs an Exclusive Agreement for "The Treatment of Skin with Adenosin or Adenosine Analog"

5.17.04
IGI Announces 1st Quarter of 2004 Results

5.4.04
IGI Inc Signs a Sublicense Agreement with Tarpan Therapeutics, In. for the Treatment of Psoriasis

4.6.04
IGI Inc. Signs Manufacturing Service Agreement with Chattem, Inc.

3.11.04
Wall Street Transcript - Interview with Frank Gerardi